Abstract 3255: Investigate immune regulation and therapeutic efficacy via regorafenib combined with PD-L1 inhibitor in glioblastoma

Authors: Dai-Cheng Dong, Yu-Chiang Liu

Published: 2023-04-04

DOI: 10.1158/1538-7445.am2023-3255

Source: Full article


Abstract

Abstract